Vincent Crabtree Email & Phone Number

Sheffield, GB

San Francisco, CA, US

• Multi-disciplinary role in an early med-device start-up focussing on non-invasive Continuous Glucose Monitoring.
• Led PMO – Defined and implemented lean processes appropriate for a high discovery R&D environment.
• Led fundamental Physiology research characterization investigations to reduce technical risk.
• Led in-house Cytotox Team and external Biocomp testing.
• Led Systems Engineering activities – Requirements Capture, verification protocol drafting and execution.
• Internal SME on IEC60601-1 compliance.

San Francisco, California, US

• Led development efforts for a Disposable wearable physiological monitor as part of the company's Remote Patient Monitoring aims to improve outcomes in COPD.
• Led Technical Feasibility for a novel, low-cost, scalable onshore manufacturing approach
• Led existing sensor Design Transfer to a Taiwanese offshore manufacturing site
• Led a DHF remediation project in-line with FDA Design Controls: Requirements Capture, Design Inputs, Risk management, Design Outputs, Biocompatibility, IEC60601, HF Validation, V&V

Franklin Lakes, New Jersey, US

• Core Team Lead for a disposable patch pump for Type 2 diabetes, originally launching Sep 2018. Achievements:
• Led Manufacturing, RA, Marketing and R&D cross functional team to prioritize go-to-market MVP feature set.
• Worked with Manufacturing to develop staged strategy that minimized risk and initial capital.
• Working with key stakeholders, developed comprehensive financial model including Capex/Opex.
• Aligned with Cross functional Senior Management and led Feasibility Exit with agreed residual risk.

San Diego, California, US

• Working with marketing and R&D, I planned new-product development roadmaps and led multiple programs:
• Developed, CE marked and 2019 limited launch G6+ Enhanced 14day CGM Product, later withdrawn
• Led Development of an improved CGM algorithm that increases data availability whilst maintaining accuracy. Included FDA 510(k) submission in compliance with iCGM Special Controls.
• Led feasibility and development of Dexcom ONE for overseas markets to leverage existing Capital expenditure

San Diego, California, US

• Led Technical Feasibility of novel CGM technologies to facilitate alternate sites and extended 14 day wear duration.

• Chair of the Artificial Pancreas program at the world’s top charity for people with Type 1 Diabetes, Juvenile Diabetes Research Foundation. Working with both Academia and Industry, developed strategy and performed due.
• Launched a major initiative to investigate/mitigate insulin infusion set failures, funding multiple research projects, and closing two industry Investment deals - Becton Dickinson & Capillary Biomedical.
• Developed an initiative to fill near-term gaps in 1st & 2nd generation closed loop systems by closing Investment deals with Bigfoot Biomedical and TidePool, & developing a pipeline including SFC Fluidics & EOFlow.
• Strategize technology pathway for 3rd generation closed loop systems & closed multiple Investments: Pacific Diabetes Technology CGM Infusion Set, Glusense Cell-Based Implantable CGM & Arecor Insulin.

• Product Development Consultant at Nemaura Medical Inc & Starfish MedicalAt Nemaura, led early Feasibility of a Non-Invasive glucose monitor for diabetes management:
• Requirements capture and technical translation of scientific requirements into verifiable specifications
• Developed PMA regulatory and clinical strategy in-line with ISO15197 CLSI CGM guidelinesConsulted at Starfish Medical, Canada’s largest Medical Device only consultancy, working on the following projects:
• IEC60601 3rd Ed. Re-Certification of Legacy Battery powered Operating Tables – required new DHF & V&V.
• Led Development of a novel Tinnitus treatment iPhone App (DHF, V&V) and 510(k) Predicate Comparison.
• Led Development of Patient Interface plastic disposables for a legacy Ventilator modernization project.

• Co-Founded & grew a university Start-Up into an ISO13485 certified company with a CE marked product & a pipeline of follow on products:
• Core Technology Inventor – Optical Assessment of Peripheral Arterial Disease, publishing journal papers
• Fund Raising – Awarded $750k in government grants, secured more than $5MM in equity funding.
• Generated & managed IP – Named inventor on multiple patent families in >50 countries.
• Technical Architect – led multiple generations of New Product Development (ISO14971 & IEC60601)

Loughborough, Leicestershire, GB

• A Principal research position developing industrial instrumentation and diagnostic equipment:
• Awarded Innovation Fellowship for Black Box technology in the OR.
• Developed electro-mechanical Proof of Concept Medical Devices: Pulse Oximetry, Inhaler Cloud Particle Characterization, Cardiovascular compliance modelling.

Phd, Non-Invasive Optical Vascular Assessment

Beng(Hons) Bachelor Of Engineering, Electronics, Communications & Control Engineering

Higher National Diploma - Associate Degree Equivalent, Electrical Engineering